1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
    Journal Article

    Hirschhorn-Cymerman, D.; Rizzuto, G. A.; Merghoub, T.; Cohen, A. D.; Avogadri, F.; Lesokhin, A. M.; Weinberg, A. D.; Wolchok, J. D.; Houghton, A. N.
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • Immune rejection of mouse tumors expressing mutated self
    Journal Article

    Duan, F.; Lin, Y.; Liu, C.; Engelhorn, M. E.; Cohen, A. D.; Curran, M.; Sakaguchi, S.; Merghoub, T.; Terzulli, S.; Wolchok, J. D.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Direct economic burden of high-risk and metastatic melanoma in the elderly: Evidence from the SEER-medicare linked database
    Journal Article

    Davis, K. L.; Mitra, D.; Kotapati, S.; Ibrahim, R.; Wolchok, J. D.
    Applied Health Economics and Health Policy (2009)

    Fulltext@MSK | Save
  • Phase I trial of a PSMA DNA vaccine for patients (pts) with good risk renal cell carcinoma (RCC)
    Meeting Abstract

    Slovin, S. F.; Motzer, R. J.; Jefferson, M.; Gregor, P.; Wolchok, J. D.; Czarny, M.; Curley, T.; Delacruz, A.; Scher, H. I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Correlation of history of tobacco consumption and type of k-ras mutation in patients (pts) with pancreatic adenocarcinoma (PC)
    Meeting Abstract

    Kelsen, D. P.; O'Reilly, E. M.; Huitzil Melendez, F. D.; Zheng, J.; Capanu, M.; Duffy, A.; Gansukh, B.; Jacobs, G.; Chapman, P. B.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Efficacy and safety of ipilimumab induction and maintenance dosing in patients with advanced melanoma who progressed on one or more prior therapies
    Meeting Abstract

    O'Day, S. J.; The Global Ipilimumab Melanoma Study Group
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Dose effect of ipilimumab in patients with advanced melanoma: Results from a phase II, randomized, dose-ranging study
    Meeting Abstract

    Hamid, O.; The Global Ipilimumab Melanoma Study Group
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in advanced melanoma
    Meeting Abstract

    Shah, G. D.; Coit, D. G.; Brady, M.; Wolchok, J. D.; Carvajal, R. D.; Busam, K.; Panageas, K.; Roman, R.; Viale, A.; Socci, N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
    Meeting Abstract

    Dummer, R.; Robert, C.; Chapman, P. B.; Sosman, J. A.; Middleton, M.; Bastholt, L.; Kemsley, K.; Cantarini, M. V.; Morris, C.; Kirkwood, J. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Novel efficacy criteria for antitumor activity to immunotherapy using the example of ipilimumab, an anti-CTLA-4 monoclonal antibody
    Meeting Abstract

    Hodi, F. S.; Hoos, A.; Ibrahim, R.; Chin, K.; Pehamberger, H.; Harmankaya, K.; O'Day, S.; Hamid, O.; Humphrey, R.; Wolchok, J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save